Eyecare professionals heading to Melbourne for the Optometry Clinical Conference can hear from Scientia Professor Fiona Stapleton and Dr Margaret Lam on the future of dry eye, and learn about one of the newest products to reach Australia, ROHTO Dry Aid.
Taking place on Sunday 17 August, attendees will be among the first to hear insights from the highly anticipated TFOS DEWS III guidelines from Prof Stapelton, offering a fresh perspective on dry eye pathophysiology and best-practice management.
The event will also mark the Australian launch of ROHTO Dry Aid, an over-the-counter therapy to address evaporative dry eye.
Dr Lam will help practitioners with practical, clinic-ready pearls as she breaks down the unique mechanism of action of ROHTO Dry Aid – and how to prescribe it in real-world patient care.
“Discover the evolving understanding of dry eye – including a first look discussion of DEWS III guidelines and impact on change in practice and the groundbreaking role of how ROHTO soothes dry eye and works on neurosensory dysregulation,” an invite to the event stated.”
“Learn how ROHTO Dry Aid uniquely addresses dry eye symptoms, and explore real-world applications to apply better prescribing insights into your daily practice.”
The event will also provide an opportunity to network with leading optometrists and dry eye enthusiasts over drinks and canapés.
Key details
Sunday, 17th August 2025
Time: 6:30pm – 9:30pm
Venue: The Emerald Peacock – Peacock Lounge Level 1, 233 Lonsdale Street, Melbourne
RSVP by Friday 15 August by emailing koula.Papamarkos@mentholatum.com.au
Places are strictly limited for this CPD-accredited event.
More reading
Rohto Dry Aid ‘redefining symptom relief in the digital age’
Optometrists going back to the future on dry eye disease
The Save Sight Institute Dry Eye Registry: Building the ‘big’ picture of dry eye
